| # | Title | Journal | Year | Citations |
|---|
| 1 | Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics | Bone Marrow Transplantation | 2013 | 12,312 |
| 2 | 1994 Consensus Conference on Acute GVHD Grading | Bone Marrow Transplantation | 1995 | 3,571 |
| 3 | Competing risk analysis using R: an easy guide for clinicians | Bone Marrow Transplantation | 2007 | 607 |
| 4 | Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH) | Bone Marrow Transplantation | 2002 | 587 |
| 5 | Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use | Bone Marrow Transplantation | 1995 | 530 |
| 6 | Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation | Bone Marrow Transplantation | 2004 | 405 |
| 7 | European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update | Bone Marrow Transplantation | 2011 | 402 |
| 8 | Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury | Bone Marrow Transplantation | 2007 | 400 |
| 9 | Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies | Bone Marrow Transplantation | 2006 | 388 |
| 10 | Regression modeling of competing risk using R: an in depth guide for clinicians | Bone Marrow Transplantation | 2010 | 387 |
| 11 | Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation | Bone Marrow Transplantation | 2016 | 364 |
| 12 | Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale | Bone Marrow Transplantation | 1997 | 360 |
| 13 | Engraftment syndrome following hematopoietic stem cell transplantation | Bone Marrow Transplantation | 2001 | 344 |
| 14 | Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually | Bone Marrow Transplantation | 2016 | 338 |
| 15 | Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study | Bone Marrow Transplantation | 1997 | 327 |
| 16 | Mesenchymal stem cell-derived exosomes for clinical use | Bone Marrow Transplantation | 2019 | 324 |
| 17 | Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia | Bone Marrow Transplantation | 2009 | 323 |
| 18 | Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective | Bone Marrow Transplantation | 2009 | 320 |
| 19 | Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium | Bone Marrow Transplantation | 1998 | 310 |
| 20 | Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report | Bone Marrow Transplantation | 2017 | 310 |
| 21 | Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009 | Bone Marrow Transplantation | 2010 | 297 |
| 22 | Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT) | Bone Marrow Transplantation | 2015 | 294 |
| 23 | An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation | Bone Marrow Transplantation | 2003 | 291 |
| 24 | Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015 | Bone Marrow Transplantation | 2015 | 283 |
| 25 | Vaccination of hematopoietic cell transplant recipients | Bone Marrow Transplantation | 2009 | 281 |
| 26 | Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines | Bone Marrow Transplantation | 2003 | 279 |
| 27 | Long term disease-free survival in acute leukemia patients recovering with increased γδ T cells after partially mismatched related donor bone marrow transplantation | Bone Marrow Transplantation | 2007 | 278 |
| 28 | Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium | Bone Marrow Transplantation | 2009 | 271 |
| 29 | Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT | Bone Marrow Transplantation | 2008 | 267 |
| 30 | Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation | Bone Marrow Transplantation | 2001 | 264 |
| 31 | Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation | Bone Marrow Transplantation | 2001 | 262 |
| 32 | AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data | Bone Marrow Transplantation | 2008 | 261 |
| 33 | Megadose transplantation of purified peripheral blood CD34+progenitor cells from HLA-mismatched parental donors in children | Bone Marrow Transplantation | 2001 | 259 |
| 34 | Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey | Bone Marrow Transplantation | 2016 | 259 |
| 35 | Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation | Bone Marrow Transplantation | 2012 | 256 |
| 36 | The EBMT risk score | Bone Marrow Transplantation | 2012 | 256 |
| 37 | Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics | Bone Marrow Transplantation | 1995 | 256 |
| 38 | Early and late hematologic toxicity following CD19 CAR-T cells | Bone Marrow Transplantation | 2019 | 254 |
| 39 | Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice | Bone Marrow Transplantation | 2014 | 252 |
| 40 | Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants | Bone Marrow Transplantation | 1992 | 252 |
| 41 | Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation | Bone Marrow Transplantation | 2003 | 247 |
| 42 | Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS | Bone Marrow Transplantation | 2012 | 245 |
| 43 | Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection | Bone Marrow Transplantation | 1999 | 243 |
| 44 | EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment | Bone Marrow Transplantation | 2018 | 243 |
| 45 | Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation | Bone Marrow Transplantation | 1998 | 240 |
| 46 | Adenovirus infection after pediatric bone marrow transplantation | Bone Marrow Transplantation | 1999 | 235 |
| 47 | Post-transplant lymphoproliferative disorder: a review | Bone Marrow Transplantation | 2003 | 234 |
| 48 | Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial | Bone Marrow Transplantation | 2008 | 233 |
| 49 | Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation | Bone Marrow Transplantation | 2000 | 232 |
| 50 | Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time | Bone Marrow Transplantation | 2005 | 232 |
